GlassScriptPhysician profile
Donald K Bishop
NPI 1801861380
$932.98
in general payments reported to CMS, 2019-2025
15 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $415 · 2020: $77.35 · 2022: $81.88 · 2023: $117 · 2024: $124 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $358.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $189.98 | 2019-2022 | |
| Abbvie INC. | $149.42 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $143.27 | 2024-2025 | Myfembree, Gemtesa |
| Allergan, INC. | $107.87 | 2019 | |
| Mayne Pharma Commercial LLC | $84.69 | 2023-2025 | |
| Exeltis, USA INC. | $62.68 | 2022-2024 | Slynd |
| Daiichi Sankyo INC. | $61.29 | 2019-2022 | |
| Avanos Medical | $33.02 | 2023 | On-Q* Pump and Accessories |
| Dexcom, INC. | $22.08 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $15.37 | 2024 | Veozah |
| Convatec INC. | $13.20 | 2020 | |
| Pfizer INC. | $13.03 | 2023 | |
| Hologic Sales and Service, LLC | $12.58 | 2019 | |
| Merck Sharp & Dohme LLC | $12.54 | 2020 | |
| Smith+Nephew, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Bishop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.